General Information
Version
6.7
Product name
Dactinomycin, United States Pharmacopeia (USP) Reference Standard
CAS No.
50-76-0
REACH No
is
Emergency telephone
+(34)-931768545
Icons in SDS
Company Information
company name
Merck Life Science S.L
e-mail address of the competent person responsible for the Safety Data Sheet
serviciotecnico@merckgroup.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H300, H350, H360FD
Hazard statements
Code
Statements
H300
Fatal if swallowed
Section 2
SECTION 2: Hazards identification
2.1 Classification of the substance or mixture
Acute toxicity, (Category 2) H300: Fatal if swallowed. Carcinogenicity, (Category 1B) H350: May cause cancer. Reproductive toxicity, (Category H360FD: May damage fertility. May 1B) damage the unborn child.
2.2 Label elements
Labelling
Signal word
Danger
Hazard statements
H300 Fatal if swallowed. H350 May cause cancer. H360FD May damage fertility. May damage the unborn child.
Precautionary statements
P201 Obtain special instructions before use. P202 Do not handle until all safety precautions have been read and understood. P264 Wash skin thoroughly after handling. P270 Do not eat, drink or smoke when using this product. P280 Wear protective gloves/ protective clothing/ eye protection/ face protection. P301 + P310 IF SWALLOWED: Immediately call a POISON CENTER/ doctor.
Supplemental label elements
none
2.3 Other hazards
This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher.
ECOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
TOXICOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.